Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2025Open Access

Identifying drivers of β-lactam/β-lactamase inhibitor resistance emergence and spread before their clinical deployment

View Full Paper
Ask AI
Bookmark
Share

Authors

KGKyle J. GontjesAPAli PiraniDNDhatri Badri Narayanan

Discussion

Loading...

Member takes

Overview

Analysis reveals factors influencing resistance in carbapenem-resistant Klebsiella pneumoniae, suggesting strategies for effective antibiotic stewardship.

Key Points

  • Main finding shows specific genetic backgrounds directly influence resistance levels in Klebsiella pneumoniae.
  • Key evidence indicates that genetic mutations in clade II are less transmissible compared to clade I's plasmid-mediated resistance.
  • Approach involved whole-genome sequencing of carbapenem-resistant bacteria before clinical use to assess resistance mechanisms.
  • Significance lies in identifying resistance drivers that can inform better surveillance and preservation of antibiotic efficacy.

Cite This Study

Gontjes et al. (2025) studied this question.

synapsesocial.com/papers/689a0c5fe6551bb0af8cf55chttps://doi.org/10.1101/2025.07.29.25331838
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MUMmer4: A fast and versatile genome alignment system2018 · 2,905 citations
  2. 2Twelve years of SAMtools and BCFtools2021 · 17,111 citations
  3. 3In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series2024 · 22 citations
  4. 4Recurrent emergence of <i>Klebsiella pneumoniae</i> carbapenem resistance mediated by an inhibitory <i>ompK36</i> mRNA secondary structure2022 · 47 citations
  5. 5Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 <i>Klebsiella pneumoniae</i>2014 · 349 citations